Arrowhead Pharmaceuticals, Inc. - Common Stock (NQ:ARWR)
Price and Volume
Detailed Quote| Volume | 1,227,796 |
| Open | 74.46 |
| Bid (Size) | 73.06 (200) |
| Ask (Size) | 73.09 (500) |
| Prev. Close | 75.16 |
| Today's Range | 72.09 - 75.43 |
| 52wk Range | 14.30 - 82.26 |
| Shares Outstanding | 105,736,200 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Arrowhead (ARWR) Q2 2026 Earnings Transcript ↗
May 08, 2026
What's going on in today's after hours session ↗
April 29, 2026
Arrowhead Pharmaceuticals to Participate in Upcoming March 2026 Events
February 24, 2026
Arrowhead (ARWR) Q1 2026 Earnings Call Transcript ↗
February 06, 2026
Frequently Asked Questions
Is Arrowhead Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Arrowhead Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Arrowhead Pharmaceuticals, Inc. - Common Stock trade on?
Arrowhead Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Arrowhead Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Arrowhead Pharmaceuticals, Inc. - Common Stock is ARWR on the Nasdaq Stock Market
What is the current price of Arrowhead Pharmaceuticals, Inc. - Common Stock?
The current price of Arrowhead Pharmaceuticals, Inc. - Common Stock is 73.09
When was Arrowhead Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Arrowhead Pharmaceuticals, Inc. - Common Stock was at 06/05/26 04:00 PM ET
What is the market capitalization of Arrowhead Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Arrowhead Pharmaceuticals, Inc. - Common Stock is 7.73B
How many shares of Arrowhead Pharmaceuticals, Inc. - Common Stock are outstanding?
Arrowhead Pharmaceuticals, Inc. - Common Stock has 8B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.